The U.S. on Wednesday authorized Pfizer Inc’s oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus and a potentially…
SYDNEY: Australia’s political leaders were set to hold an emergency meeting on Wednesday as cases of the Omicron coronavirus variant broke infection records and forced countries around to world to…
Pfizer Inc and BioNTech SE’s Covid-19 shot yielded the strongest immune response among four vaccines tested in a study, which found people getting Sinopharm’s inoculation may be particularly susceptible to…
By Michael Erman and Manas Mishra Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices…
By Michael Erman NEW YORK – The U.S. Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and…
By Michael Erman and Julie Steenhuysen Scientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency’s criteria to support…
